Coherus Oncology (NASDAQ:CHRS – Get Free Report) released its quarterly earnings results on Wednesday. Coherus Oncology had a negative net margin of 259.41% and a negative return on equity of 211.76%. Coherus Oncology Price PerformanceShares of NASDAQ:CHRS traded up $0.12 on Friday, reaching $1.39. Coherus Oncology has a 52-week low of $0.81 and a 52-week high of $2.62. Further ReadingReceive News & Ratings for Coherus Oncology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coherus Oncology and related companies with MarketBeat.com's FREE daily email newsletter.